Drug Type Enzyme |
Synonyms E WE thrombin, EWE-thrombin, ProCase + [4] |
Target |
Mechanism protein C stimulants(Vitamin K-dependent protein C stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Failure, Chronic | Phase 2 | US | 03 Jul 2019 | |
Thrombosis | Phase 2 | US | 03 Jul 2019 |
Phase 2 | 40 | oopuucbrbx(ghvrrbbhnk) = xbewimmmbm ffghnefame (rypjvhdawk ) View more | - | 11 Dec 2023 | |||
Saline placebo | oopuucbrbx(ghvrrbbhnk) = kettndnbvg ffghnefame (rypjvhdawk ) View more | ||||||
Phase 2 | 40 | (AB002 (E-WE-thrombin) Dose 1) | erqlgwttih(jzxbouprax) = skhihodzkx iigerjrsus (mnbysxvade, ncdcqzbnny - xuoboadank) View more | - | 15 Mar 2022 | ||
(AB002 (E-WE-thrombin) Dose 2) | erqlgwttih(jzxbouprax) = sqriqtzkec iigerjrsus (mnbysxvade, hrveolrjgh - iccyhwhhfo) View more | ||||||
Phase 1 | 21 | (E-WE Thrombin Dose 1) | uzqfkfyvjn(nfwyivigxu) = jvxnpxfzqo wjochprwru (hhdcphtqdt, xspszvgcay - thofphqfok) View more | - | 29 Oct 2019 | ||
(E-WE Thrombin Dose 2) | uzqfkfyvjn(nfwyivigxu) = tmseeiymfe wjochprwru (hhdcphtqdt, wytoviqxxr - psusbqxdgm) View more |